ES2060146T3 - Metaloproteinasas colagenoliticas asociadas con metastasis. - Google Patents

Metaloproteinasas colagenoliticas asociadas con metastasis.

Info

Publication number
ES2060146T3
ES2060146T3 ES90903555T ES90903555T ES2060146T3 ES 2060146 T3 ES2060146 T3 ES 2060146T3 ES 90903555 T ES90903555 T ES 90903555T ES 90903555 T ES90903555 T ES 90903555T ES 2060146 T3 ES2060146 T3 ES 2060146T3
Authority
ES
Spain
Prior art keywords
enzyme
disclosed
found
methods
rat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90903555T
Other languages
English (en)
Inventor
Motowa Nakajima
Garth L Nicolson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Application granted granted Critical
Publication of ES2060146T3 publication Critical patent/ES2060146T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE REVELAN METODOS Y COMPOSICIONES PARA TESTAR VARIOS TIPOS DE CANCERES HUMANOS, INCLUYENDO EN PARTICULAR CARCINOMA METASTATICO MAMARIO, ASTRACITOMA COLON CARCINOMA, CARCINOMA DE CELULA RENAL, Y MELANOMA TERATOCARCINOMA MALIGNO. EL METODO DE DIAGNOSTICO DE LA INVENCION COMPRENDE LA DETECCION DE METALOPROTEINAS GELATINOLITICAS Y COLAGENOLITICAS TIPO IV TENIENDO UN PESO MOLECULAR DE APROXIMADAMENTE DE 88 A 92 KILODALTONS. ESTE ALTO PESO MOLECULAR DE LA ENZIMA COLAGENOLITICA TIPO IV SE OBSERVA ESTA ASOCIADO CON EL ESTADO CANCEROSO, PUES NO SE OBSERVA EN NINGUNA DE LAS CELULAS NO CANCEROSAS TESTADAS Y ADEMAS TAMPOCO SE HA VISTO EN EL SUERO DE LOS ANIMALES PORTADORES SIN TUMOR. LA ENZIMA ESTA ASOCIADA CON TUMORES DE RATA Y HUMANO, SIENDO LA ENZIMA EN AMBOS CASOS BASTANTE SIMILAR. SE REVELAN METODOS PARA EL AISLAMIENTO DE LA ENZIMA 88/92 KD, SIENDO LA ENZIMA AISLADA UTIL PARA SU USO COMO ENZIMA CONTROL Y ANALISIS DIAGNOSTICOS. ADEMAS, LA ENZIMA AISLADA ES UTIL PARA LA PREPARACION DE ANTICUERPOS,INCLUYENDO ANTICUERPOS MONOCLONALES, TENIENDO ESPECIFICIDAD PARA LA ENZIMA ASOCIADA A METASTASIS. TAMBIEN SE REVELAN TECNICAS PARA EL AISLAMIENTO Y PURIFICACION PARCIAL DE LA ENZIMA A PARTIR DE RATA Y HUMANOS. ADEMAS SE REVELAN METODOS PARA LLEVAR A CABO PRUEBAS ENZIMATICAS E INMUNOLOGICAS PARA EL DIAGNOSTICO DE ENFERMEDADES METASTATICAS Y RECURRENTES.
ES90903555T 1989-02-27 1990-01-29 Metaloproteinasas colagenoliticas asociadas con metastasis. Expired - Lifetime ES2060146T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31626089A 1989-02-27 1989-02-27

Publications (1)

Publication Number Publication Date
ES2060146T3 true ES2060146T3 (es) 1994-11-16

Family

ID=23228283

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90903555T Expired - Lifetime ES2060146T3 (es) 1989-02-27 1990-01-29 Metaloproteinasas colagenoliticas asociadas con metastasis.

Country Status (9)

Country Link
EP (1) EP0460016B1 (es)
JP (1) JPH04505699A (es)
AT (1) ATE98685T1 (es)
AU (1) AU639906B2 (es)
CA (1) CA2048695A1 (es)
DE (1) DE69005297T2 (es)
DK (1) DK0460016T3 (es)
ES (1) ES2060146T3 (es)
WO (1) WO1990010062A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1994005807A1 (en) * 1992-08-28 1994-03-17 Dickson Robert B Matrix-degrading metalloproteinase
WO1997009420A2 (en) * 1995-09-05 1997-03-13 Celltech Therapeutics Limited Dna sequences coding for a human metalloproteinase and variants thereof
US7041787B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US20130217034A1 (en) 2010-08-13 2013-08-22 Dentognostics Gmbh Process for avoiding false positive results in a detecting process of an inflammation indicator in a rinse solution for taking up gingival crevicular fluid

Also Published As

Publication number Publication date
DE69005297D1 (de) 1994-01-27
DE69005297T2 (de) 1994-04-21
WO1990010062A1 (en) 1990-09-07
AU5104790A (en) 1990-09-26
ATE98685T1 (de) 1994-01-15
DK0460016T3 (da) 1994-04-25
EP0460016B1 (en) 1993-12-15
AU639906B2 (en) 1993-08-12
EP0460016A1 (en) 1991-12-11
JPH04505699A (ja) 1992-10-08
CA2048695A1 (en) 1990-09-28

Similar Documents

Publication Publication Date Title
Goldschneider et al. Demonstration of terminal deoxynucleotidyl transferase in thymocytes by immunofluorescence.
Nuti et al. A monoclonal antibody (B72. 3) defines patterns of distribution of a novel tumor‐associated antigen in human mammary carcinoma cell populations
Li et al. Immunohistochemical diagnosis of prostatic cancer with metastasis
Kawaguchi et al. CYFRA 21‐1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences
Franks Etiology, epidemiology, and pathology of prostatic cancer
Kupchik et al. Carcinoembryonic antigen (s) in liver disease: II. Isolation from human cirrhotic liver and serum and from normal liver
KR880006358A (ko) 새로운 뮤친 에피토프에 대한 모노클로날항체 생산용 잡종체
CA2164498A1 (en) Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US4379839A (en) Method for detecting cancer
Huber et al. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen
EP0284429A3 (en) Antibodies to human cancer nucleolar antigen pl20, corresponding cell lines, and their preparation and use in the detection of human cancer cells
Fukutomi et al. Prognostic contributions of Helix pomatia and carcinoembryonic antigen staining using histochemical techniques in breast carcinomas
Andreadis et al. Serum CYFRA 21–1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy
Chu Prostate-specific antigen and early detection of prostate cancer
Yamashita et al. Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer
ES2060146T3 (es) Metaloproteinasas colagenoliticas asociadas con metastasis.
ES8605904A1 (es) Metodo inmunologico para la deteccion de celulas malignas con actividad metastatica
SE9500030D0 (sv) Method of determining metastatic potential of tumor cells
WALKER Mucoid carcinomas of the breast: a study using mucin histochemistry and peanut lectin
ES8802196A1 (es) Metodo para determinar la presion de un estado maligno en tejidos.
Chu Serum Acid Phosphohydrolase (Phosphatase) and Ribonuclease in Diagnosis of Prostatic Cancer1
BÁnfalvi et al. Serum levels of S-100 protein and 5-S-cysteinyldopa as markers of melanoma progression
Rogalsky et al. Macro creatine kinase type 2 in human colonic tissues
Pour et al. Lectin binding affinities of induced pancreatic lesions in the hamster model
US5087573A (en) Monoclonal antibody against bone alkaline phosphatase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 460016

Country of ref document: ES